Consuming vitamin D supplements may cut the risk of acquiring pancreatic cancer by nearly half according to a recent study led by researchers from Harvard and Northwestern universities in the US.
Go deeper with GlobalData
The findings, appearing in the journal Cancer Epidemiology Biomarkers & Prevention, come from the first known study to use large-scale epidemiological surveys (researchers analysed two large, long-term health surveys) to examine the relationship between the nutrient and pancreatic cancer.
The study found that taking the US Recommended Daily Allowance of Vitamin D (400 IU/day) reduced the risk of pancreatic cancer by 43%. Those who consumed less than 150 IUs per day experienced a 22% reduced risk of cancer. Increased consumption of the vitamin beyond 400 IUs per day resulted in no significant increased benefit.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
Study leader Dr Halcyon Skinner said: “Because there is no effective screening for pancreatic cancer, identifying controllable risk factors for the disease is essential for developing strategies that can prevent cancer.”
